• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Circulation of Influenza and Other Respiratory Viruses in Tunisia, 2022-2023 Season

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2026 May;20(5):e70199.
doi: 10.1111/irv.70199.
Circulation of Influenza and Other Respiratory Viruses in Tunisia, 2022-2023 Season

Bouslah Zoubeir[SUP] 1 2 [/SUP], Bouguerra Hind[SUP] 3 4 [/SUP], Dhaouadi Sonia[SUP] 4 5 [/SUP], Abid Salma[SUP] 1 2 [/SUP], Whitehouse Erin Rachel[SUP] 6 [/SUP], El Ghord Hakim[SUP] 7 [/SUP], Yazidi Rihab[SUP] 8 [/SUP], Ben Mrad Nacef[SUP] 9 10 11 [/SUP], Miraoui Amal[SUP] 10 12 [/SUP], Bougharriou Ichrak[SUP] 13 14 [/SUP], Ennouri Emna[SUP] 15 16 [/SUP], Ben Slimen Najla[SUP] 10 11 17 [/SUP], Guebsi Nour El Houda[SUP] 10 12 [/SUP], Toumi Radhouane[SUP] 15 16 [/SUP], Bouabid Leila[SUP] 5 [/SUP], Ben Hamida Chokri[SUP] 14 18 [/SUP], Merhabane Takoua[SUP] 10 11 17 [/SUP], Boussarsar Mohamed[SUP] 15 16 [/SUP], Ben Jemaa Mounir[SUP] 13 14 [/SUP], Menif Khaled[SUP] 10 12 [/SUP], Ben Khelil Jalila[SUP] 9 10 11 [/SUP], Ben Alaya Nissaf[SUP] 4 5 [/SUP], Ben Salah Afif[SUP] 19 20 [/SUP], Laouini Dhafer[SUP] 8 [/SUP], Zureick Kinda[SUP] 6 [/SUP], Boutiba-Ben Boubaker Ilhem[SUP] 1 2 [/SUP]


Affiliations
Abstract

Introduction: Influenza sentinel surveillance has been ongoing in Tunisia since 1999. We describe the epidemiology of respiratory viruses during 2022-2023, the first season to include testing for other respiratory viruses, such as respiratory syncytial virus (RSV).
Methods: We analyzed weekly surveillance data from severe acute respiratory infection (SARI) inpatients and influenza-like illness outpatients from 11 hospitals and 85 clinics in Tunisia. Nasopharyngeal specimens and demographic, clinical, and vaccination data were collected. Specimens were tested by rRT-PCR for influenza, SARS-CoV-2, RSV, and 18 other respiratory viruses. Descriptive statistics were used to summarize case characteristics; group differences were assessed using chi-squared or Fisher's exact tests.
Results: 2038 specimens were collected from unique patients; 1231 (60.4%) were positive for ≥ 1 respiratory virus and 200 (16.2%) were positive for ≥ 2 viruses. Influenza was the most detected (n = 445; 21.8%), followed by rhinovirus (n = 301, 14.8%), RSV (n = 255, 12.5%), and SARS-CoV-2 (n = 125, 6.1%). Among SARI cases, infections with influenza and SARS-CoV-2 were more common in adults ≥ 50 years (61.8% and 71.4%, respectively), while children < 2 years had higher RSV prevalence (83.0%, adjusted p-value = 0.004). 4.9% of patients received a recent influenza vaccine.
Conclusion: The burden of respiratory viruses varied by age, with RSV being more prevalent among younger children and SARS-CoV-2 and influenza being more prevalent among older adults. Ongoing sentinel surveillance is essential to monitor priority respiratory pathogens, particularly those with available public health interventions, such as vaccination, to enable timely action and reduce disease burden.

Keywords: RSV; SARS‐CoV‐2; acute respiratory infections; influenza; respiratory viruses; sentinel surveillance.

 
Back
Top